Background: Recently, several new atypical antipsychotic agents have been introduced in
Ontario, and regulatory warnings have been issued regarding use of atypical antipsychotics …

Prescriptions for antipsychotics (AP) to elderly patients in Canada have increased by nearly
32% over the past 4 years, from 2,954,248 prescriptions dispensed in the last quarter of …

Background: The introduction of new antipsychotic agents in the past decade has helped
alter the treatments available to 2 vulnerable populations—those with schizophrenia and …

Objective The purpose of this study was to assess trends in utilization and costs of
antipsychotic drugs among a population of older adults over time, with respect to the …

Background: Given the common off-label use of antipsychotics (AP), we aimed to assess the
factors associated with this use in community living older adults. Methods: The study sample …

Background: Public health advisories have warned that the use of atypical antipsychotic
medications increases the risk of death among elderly patients. We assessed the short-term …

Objectives: This study examined the determinants of atypical antipsychotic use among
antipsychotic users in community-dwelling elderly in the United States. Methods: The study …

Antipsychotic agents, especially second-generation agents, are often used among elderly
persons for behavioral symptoms of dementia and psychoses. However, recent trials …

Background Recently, the Food and Drug Administration (FDA) issued an advisory stating
that atypical antipsychotic medications increase mortality among elderly patients. However …

Context Atypical antipsychotic medications are commonly used for off-label conditions such
as agitation in dementia, anxiety, and obsessive-compulsive disorder. Objective To perform …